BMJ  2008;336:57-58 (12 January), doi:10.1136/bmj.39426.672118.80 (published 8 January 2008)

Editorials

Managing severe pneumonia in children in developing countries

Increasing resistance to first line antibiotics means recommendations need changing

The first 150 words of the full text of this article appear below.

Despite advances in our understanding of the epidemiology and distribution of deaths from pneumonia,¹ more than 150 million cases of pneumonia still occur annually, with almost 2.4 million deaths worldwide. Pneumonia is perhaps the most frequent cause of death in children under 5, including during the newborn period.² Deaths from pneumonia in children have increased in the wake of the HIV epidemic in Africa. Most deaths occur early in the course of illness. Because severe pneumonia is usually related to bacterial infection, treatment has largely focused on various antibiotic strategies.

In the accompanying randomised controlled trial, Asghar and colleagues compare the effectiveness of injectable ampicillin plus gentamicin or chloramphenicol in children aged 2-59 months with severe pneumonia (defined by World Health Organization criteria).³ The trial took place in inpatient wards in tertiary care hospitals in Bangladesh, Ecuador, India, Mexico, Pakistan, Yemen, and Zambia. Significantly more children failed treatment with chloramphenicol . . . [Full text of this article]

¹ Department of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Articles

Parliament unites to tackle global problem

Des Turner and Richard Taylor
BMJ 2008 336: 233-234. [Extract] [Full Text] [PDF]

Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study)

Rai Asghar, Salem Banajeh, Josefina Egas, Patricia Hibberd, Imran Iqbal, Mary Katep-Bwalya, Zafarullah Kundi, Paul Law, William MacLeod, Irene Maulen-Radovan, Greta Mino, Samir Saha, Fernando Sempertegui, Jonathon Simon, Mathuram Santosham, Sunit Singhi, Donald M Thea, Shamim Qazi for the SPEAR (Severe Pneumonia Evaluation Antimicrobial Research) Study Group
BMJ 2008 336: 80-84. [Abstract] [Full Text] [PDF]

Chest radiography in children aged 2-59 months diagnosed with non-severe pneumonia as defined by World Health Organization: descriptive multicentre study in Pakistan

Tabish Hazir, Yasir Bin Nisar, Shamim A Qazi, Shazia F Khan, Mujahid Raza, Shehla Zameer, and Syed Asif Masood
BMJ 2006 333: 629. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

• Turner, D., Taylor, R. (2008). Parliament unites to tackle global problem. BMJ 336: 233-234 [Full text]